At some point almost all health care journalists will need to cover a medical study or two. When that happens, you’ll want to have at least a passing understanding of p values and statistics and you’ll need to know that correlation does not imply causation.
For a session on May 2, AHCJ’s medical studies topic leader Tara Haelle moderated a panel, “Begin mastering medical studies.” Haelle and two experts in the topic explained some of the finer points of covering studies: Ishani Ganguli, M.D., an assistant professor of medicine at the Harvard Medical School, and an internal medicine physician at Brigham and Women’s Hospital; and Regina Nuzzo, Ph.D., a freelance journalist and professor of science, technology and mathematics at Gallaudet University. Continue reading
Photo: CDC/ Melissa Dankel
Researchers are looking to old drugs, plants and viruses in a race to find new ways to kill disease-causing microbes before they become resistant to all existing pharmaceuticals, but their work will flounder if the federal government can’t figure out how to incentive companies to turn their work into commercially viable drugs. Continue reading
Covering medical conferences is the bread and butter of many health journalists, especially if they write for trade publications. A previous tip sheet offered tips for how to prepare for covering a medical conference, and now we’ve compiled a tip sheet aimed at making the most of a conference while you’re on the ground rushing from session to session.
Policies, schedules, location layout, press room amenities, conference structure and other characteristics vary from one conference to another, but most of the tips we offer will apply to nearly every research conference, big or small, in any discipline or subspecialty. Continue reading
In a recent commentary in JAMA Neurology, Elisa de Paula França Resende, M.D., of the University of California, San Francisco, and colleagues write about how social determinants of health affect demographic patterns of dementia in the United States. Noting that with an aging population, the prevalence of dementia will increase substantially, Resende and her co-authors write that of the social determinants affecting dementia risk, health and socioeconomics act more strongly than do race or cultural identifiers. I will add here that being female also is involved in dementia risk, as women are at greater risk for it than men. Continue reading
It’s an easy trap to fall into: call the hospital public relations department and ask to speak with an authority about your topic. Chances are good you will end up interviewing an older, typically white, male doctor.
And while there’s nothing inherently wrong with that, if you’re only talking to one group of experts, you’re missing out on vital sources which can add rich, diverse perspectives to your stories, according to the journalists who participated in the “Finding diverse sources for your story” panel at Health Journalism 2019. Besides, diversity is just good journalism. Continue reading
Otis Brawley, M.D., and Matthew Ong, of The Cancer Letter, were on the panel “How precision medicine and immunotherapy are redefining the approach to cancer treatment.”
Are precision medicine and immunotherapy overhyped as cancer treatments, or do they hold such tremendous promise that we are only just starting to see the potential?
That was the overarching question for the panel discussion at Health Journalism 2019, “How precision medicine and immunotherapy are redefining cancer treatment.”
“I do worry that precision medicine and immunotherapy are overhyped,” said Otis W. Brawley, M.D., Bloomberg distinguished professor of oncology and epidemiology at the Bloomberg School of Public Health and John Hopkins Kimmel Cancer Center. Brawley also was the Thursday night speaker at Health Journalism 2019. Continue reading